BRISTOL MYERS SQUIBB CO 4

Cristian Massacesi, EVP and Chief Medical Officer of Bristol Myers Squibb (BMY), sold 6,249 shares of common stock for about $404K.

On September 9, 2026, Cristian Massacesi, EVP, Chief Medical Officer and Head of Development at Bristol Myers Squibb Co., sold 6,249 shares of the company’s common stock at an average price of approximately $64.57 per share, for total proceeds of about $403,700. Following this disposition, Massacesi directly owned 18,748 shares of Bristol Myers Squibb common stock. Using the reported sale price as a proxy for current valuation, his post-transaction direct holdings are worth roughly $1.21 million. The transaction was reported as a standard open-market sale (code “S”) and does not appear to be associated with options, RSUs, or other equity awards.

Filing Facts

CIK

14272

Ticker

BMY

Form

4

Source Type

fda

Accession

0002080176-26-000006

Alert Tier

6